Health
Regeneron’s Antibody Combination Therapy Reduces COVID-19 Mortality Risk – BioPharm International
RECOVERY trial results have shown that Regeneron’s investigational antibody combination therapy reduces the mortality risk for…
Results of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial have shown that Regenerons investigational antibody combination therapy reduces the mortality risk for hospitalized patients with severe COVID-19 whose immune response has not started…
Continue Reading
-
Noosa News21 hours agoTalented new artist on jazz scene
-
Noosa News21 hours agoUn-beer-lievable: SEQ costlier than Melbourne for housing, food, grog
-
Business17 hours agoTop brokers name 3 ASX shares to buy next week 13 April 2025
-
Noosa News18 hours agoPeter Andrews was dismissed as ‘a lunatic’ now his son’s family farm is proof of his vision